We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$11.3B
AUM Growth
+$1.62B
Cap. Flow
+$896M
Cap. Flow %
7.96%
Top 10 Hldgs %
56.76%
Holding
110
New
30
Increased
24
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
EFX icon
Equifax
EFX
+$171M
2
TWX
Time Warner Inc
TWX
+$146M
3
NXPI icon
NXP Semiconductors
NXPI
+$145M
4
KITE
Kite Pharma, Inc.
KITE
+$136M
5
TRU icon
TransUnion
TRU
+$106M

Top Sells

Rank Stock Value
1
MBLY
Mobileye N.V.
MBLY
+$371M
2
SBAC icon
SBA Communications
SBAC
+$132M
3
TMH
Team Health Holdings Inc
TMH
+$105M
4
ALR
Alere Inc
ALR
+$82.4M
5
META icon
Meta Platforms (Facebook)
META
+$75.8M

Sector Composition

Rank Sector Weight
1 Technology 23.58%
2 Healthcare 20.65%
3 Communication Services 20.02%
4 Industrials 7.53%
5 Financials 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
51
Ionis Pharmaceuticals
IONS
$9.93B
$22.8M 0.2%
+450,000
New +$23.6M
LUMN icon
52
PUT
Lumen
LUMN
$6.13B
$21.6M 0.19%
+1,144,000
New +$24.1M
SVRA icon
53
Savara
SVRA
$1.15B
$20.8M 0.18%
2,225,000
– –
RYAAY icon
54
Ryanair
RYAAY
$28.9B
$20.6M 0.18%
488,455
-108,578
-18% -$4.9M
SNI
55
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$20.2M 0.18%
+235,000
New +$19.3M
SBAC icon
56
SBA Communications
SBAC
$19.4B
$19.7M 0.18%
136,738
-924,231
-87% -$132M
ENTA icon
57
Enanta Pharmaceuticals
ENTA
$392M
$19.3M 0.17%
+412,333
New +$16.6M
MYOK
58
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$17M 0.15%
+397,500
New +$12.7M
SPB icon
59
Spectrum Brands
SPB
$2B
$15.6M 0.14%
+147,000
New +$16.5M
HRG
60
DELISTED
HRG Group, Inc.
HRG
$15.4M 0.14%
+985,000
New +$15.9M
SAGE
61
DELISTED
Sage Therapeutics
SAGE
$15.2M 0.13%
243,500
+143,500
+144% +$11.3M
AKBA icon
62
Akebia Therapeutics
AKBA
$251M
$14.4M 0.13%
730,000
– –
RGNX icon
63
Regenxbio
RGNX
$708M
$13.7M 0.12%
+417,000
New +$9.38M
STML
64
DELISTED
Stemline Therapeutics, Inc.
STML
$13.2M 0.12%
1,187,500
+30,000
+3% +$282K
ZEAL
65
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$12.5M 0.11%
+650,000
New +$12.2M
ZGNX
66
DELISTED
Zogenix, Inc.
ZGNX
$11.2M 0.1%
320,000
+145,000
+83% +$1.97M
CLLS
67
Cellectis
CLLS
$342M
$11M 0.1%
+385,000
New +$9.96M
MON
68
DELISTED
Monsanto Co
MON
$10.8M 0.1%
90,000
-125,000
-58% -$14.7M
WGL
69
DELISTED
Wgl Holdings
WGL
$10.1M 0.09%
120,000
– –
CYOU
70
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$9.51M 0.08%
240,000
+79,188
+49% +$3.19M
ANAB icon
71
AnaptysBio
ANAB
$1.71B
$8.6M 0.08%
+246,000
New +$6.64M
NCNA
72
NuCana
NCNA
$6.33M
$7.35M 0.07%
+80
New +$6.9M
MRNS
73
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$6.87M 0.06%
+292,500
New +$3.28M
IOVA icon
74
Iovance Biotherapeutics
IOVA
$3.76B
$6.59M 0.06%
+850,000
New +$5.38M
PCO
75
DELISTED
Pendrell Corporation - Class A
PCO
$5.61M 0.05%
8,211
– –
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2017 Portfolio in Review

As of Q3 2017, Thomas Steyer held 110 positions worth $11.3B, up 17% from $9.63B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Thomas Steyer deployed $896M of net new capital in Q3 2017, opening 30 new positions and adding to 24 existing holdings. Its largest new stake was Equifax: 1,290,000 shares worth $137M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was SBA Communications, an estimated $132M trimmed.

  • Thomas Steyer's largest Q3 2017 buy was Equifax: 1,290,000 shares worth $137M.
  • Thomas Steyer added most to Time Warner Inc in Q3 2017, an estimated $146M increase.
  • Thomas Steyer's biggest Q3 2017 reduction was SBA Communications, cutting an estimated $132M.
  • Thomas Steyer fully exited Mobileye N.V. in Q3 2017, selling an estimated $371M.
  • Thomas Steyer's ten largest holdings make up 57% of its $11.3B portfolio in Q3 2017.
  • Thomas Steyer opened 30 new positions and closed 25 in Q3 2017.
  • Thomas Steyer's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on Farallon Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.